Novavax Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
51,983.00
82,947.00
156,937.00
279,966.00
183,769.00
Depreciation, Depletion & Amortization
2,591.00
4,424.00
5,983.00
8,505.00
9,817.00
Other Funds
1.00
173.00
126.00
39,340.00
-
Funds from Operations
46,007.00
72,591.00
136,103.00
247,996.00
147,802.00
Changes in Working Capital
1,079.00
4,457.00
46,217.00
10,772.00
11,186.00
Net Operating Cash Flow
44,928.00
68,134.00
89,886.00
258,768.00
136,616.00
Capital Expenditures
5,785.00
7,268.00
18,286.00
18,213.00
4,189.00
Sale of Fixed Assets & Businesses
3,150.00
39.00
18.00
11.00
-
Purchase/Sale of Investments
19,027.00
122,604.00
3,002.00
46,219.00
40,157.00
Net Investing Cash Flow
16,392.00
129,833.00
21,270.00
28,017.00
35,968.00
Issuance/Reduction of Debt, Net
890.00
795.00
667.00
314,568.00
37.00
Net Financing Cash Flow
131,035.00
109,717.00
208,283.00
279,030.00
64,540.00
Net Change in Cash
102,503.00
88,256.00
96,977.00
47,944.00
35,966.00
Free Cash Flow
50,713.00
75,402.00
108,172.00
276,981.00
140,805.00
Change in Capital Stock
130,146.00
110,685.00
209,076.00
3,802.00
64,577.00
Exchange Rate Effect
4.00
6.00
150.00
335.00
142.00
About Novavax
View Profile
